Drug Discovery News: Breaking Drug Discovery News, Comments and Articles. - Page: 4

12:24 EST 18th December 2014 | BioPortfolio

Drug Discovery News - Page: 4Twitter RSS

Read the latest Drug Discovery News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Drug Discovery.

Search or Follow Our Drug Discovery - Page: 4 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Drug Discovery - Page: 4 News.
You can also follow our Drug Discovery - Page: 4 news stories on Twitter: @DiscoveryDrug

Showing "drug drug discovery discovery" News Articles 76 to 100 of 27,000+

Thursday 18th December 2014

D-Pharm Achieves Primary End-point in Phase 2 Clinical Study of THR-18 in Acute Stroke Patients Treated With tPA

REHOVOT, Israel, December 18, 2014 /PRNewswire/ -- D-Pharm Ltd. (TASE: DPRM) reported today, December 18th, 2014, that its Phase 2 clinical study of THR-18 successfully achieved its primary endpoint in acute ischemic stroke (AIS) patients treated with tissue plasminogen activator (tPA). THR-18 demonstrated statistically significant reductions in the incidence of intracranial hemorrhage (ICH), bra...

HUYA Bioscience International Establishes Alliance with China Wuqing Development Area

SAN DIEGO, Dec. 18, 2014 /PRNewswire/ -- HUYA Bioscience International, a leader in accelerating the global development of China's pharmaceutical innovations, today announced a strategic collaboration agreement with China Wuqing Development Area, a state-level economic and technological development area located between Beijing and Tianjin. The collaboration will focus on promoting biomedical innov...

Scioderm, Inc. Closes $20 Million Series B Round of Financing

DURHAM, N.C., Dec. 18, 2014 /PRNewswire/ -- Scioderm, Inc., today announced it raised $20 million in a Series B financing round led by Redmile Group, a new investor in the Company. The proceeds will be used to fund the development of ZorblisaTM (SD-101), a proprietary topical therapy being developed for the treatment of all patients with Epidermolysis Bullosa (EB), through completion of the U...

Xencor and Novo Nordisk Enter Discovery Collaboration Using Xencor's XmAb Bispecific and Immune Inhibitor Technologies

MONROVIA, Calif., Dec. 18, 2014 /PRNewswire/ -- Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer, today announced that it has entered into a collaboration and licensing agreement with Novo Nordisk to jointly discover novel biologic drug candidat...

Hutchison MediPharma Starts Phase III Trial of Cancer Drug

Last week, Hutchison MediPharma, a division of Chi-Med, dosed the first patient in a China Phase III clinical trial of fruquintinib (HMPL-013), a treatment for solid tumor cancers. The trial will enroll more than 400 patients with advanced colorectal...

CE-Classes.com Announces New Online Course for Healthcare Providers

Approved online continuing education company announces addition of new course for healthcare providers. The course will assist in explaining the DSM-5, the manual for psychological disorders. Fort Lauderdale, FL (PRWEB) December 18, 2014 CE-Classes.com has announced the addition of a new online course – DSM-5 Overview and Substance Abuse. This course on the DSM-5 is designed for healthcare prov...

Version 13 of the Human Protein Atlas, Clickable, Downloadable, and Nearly Complete, is Now Online

Bio-IT World | A new version of a research tool described as the world’s first spatial index to the human proteome is expected to change the nature of drug development, and is already the source of some two external peer-reviewed research papers on...

MFI Recovery Center Services Selects Core Solutions

MFI Utilizes 2nd Generation EHR To Transform West Coast Behavioral Health Community. King of Prussia, PA (PRWEB) December 18, 2014 MFI Recovery Center (MFI) a behavioral health provider serving the residents of California and Core Solutions, Inc. (Core) the progressive leader in integrated behavioral health Electronic Health Records (EHR) that transform the behavioral, medical and social services...

Androgel Testosterone Lawsuit Trials Develop; Coordination Questions Arise

Attorneys handling national testosterone lawsuits provide weekly testosterone lawsuit news updates and no-obligation case review at the Onder Law Firm's website, AndrogelTestosteroneLawsuitCenter.com. St. Louis, MO (PRWEB) December 18, 2014 Testosterone lawsuits, which have been consolidated as a multidistrict litigation, are progressing in U.S. District Court in Northern Illinois, according ...

Invibio Biomaterial Solutions' PEEK-OPTIMA® HA Enhanced Receives First European Approval for Implant

Implantable polymer adopted by Karmed Saglik Group for spinal fusion device Thornton Cleveleys (UK) (PRWEB) December 18, 2014 Implants made from the PEEK-OPTIMA® HA Enhanced implantable polymer have received their first CE mark (European) approval. It is granted to implants supplied by the Karmed Saglik Group (“Karmed”) for the treatment of degenerative spinal conditions. The approval i...

Roche wins drug discovery award for Gazyvaro

Roche has been named the winner of the 2015 Drug Discover of the Year award by the British Pharmacological Society (BPS) for its leukaemia medicine Gazyvaro. Gazyvaro (obinutuzumab), marketed as Gazyva outside the EU, is the first in a new class of antibody drugs that treat chronic lymphocytic leukaemia (CLL) by attacking cells both directly and together with the immune system. read more

AstraZeneca first-in-class ovarian cancer drug wins EU approval

LONDON (Reuters) - AstraZeneca's all-important cancer drug business received a fillip on Thursday as a new medicine against ovarian cancer was approved in Europe, making it the first of its kind to reach the market.

Elekta Flexitron brachytherapy treatment delivery available in China

BEIJING, Dec. 18, 2014 /PRNewswire/ -- Elekta (EKTA-B.ST) announces that the China Food and Drug Administration (CFDA) has approved Elekta's Flexitron® brachytherapy afterloading platform for sale and marketing in China. In China there is a high prevalence of gynecologic cancers, as well lung, breast, colorectum and esophagus cancers. Many patients with such cancers can be effectiv...

Horizon Discovery Group plc and Adarza BioSystems Enter Supply & Licensing Agreement

Agreement gives Horizon exclusive right to supply services on Adarza’s multiplex label-free immunoassay technology Horizon Discovery Group plc (LSE:HZD), a leading provider of research tools to support translational genomics and the development of personalized medicines, and Adarza BioSystems, Inc., a next generation innovator in label-free, multiplex assays, announced today that they have e...

Cipher Pharmaceuticals Inc. Announces Adoption of Advance Notice By-Law

Toronto Stock Exchange Symbol: CPHNASDAQ Symbol: CPHR MISSISSAUGA, ON, Dec. 18, 2014 /PRNewswire/ - Cipher Pharmaceuticals Inc. (the "Company") (TSX: CPH; NASDAQ: CPHR) ("Cipher" or "the Company") announced today that its Board of Directors has approved a By-Law (the "Advance Notice By-Law") that requires advance notice to the Company where director nominations are made by shareholders of ...

Celator® Pharmaceuticals Receives European Patent Allowance on Nanoparticle Delivery Technology

EWING, N.J., Dec. 18, 2014 /PRNewswire/ -- Celator Pharmaceuticals, Inc. (Nasdaq: CPXX), a biopharmaceutical company transforming the science of combination therapy and developing products to improve patient outcomes in cancer, today announced that the application of European patent number 2,222,278 was allowed by the European Patent Office.  The new patent, "Improved Taxane Delivery System,"...

Sorin obtains FDA approval for Memo 3D ReChord annuloplasty ring

Medical device company Sorin Group has received approval from the US Food and Drug Administration (FDA) for its Memo 3D ReChord, a semi-rigid annuloplasty ring for mitral valve repair.

HedgePath gets FDA nod to begin proposed cancer drug development

HedgePath Pharmaceuticals has received clearance from the US Food and Drug Administration (FDA) for the first investigational new drug (IND) application to start development of its proposed cancer treatment.

BioLineRx, Novartis to develop and commercialize Israeli-sourced drug candidates

Clinical-stage biopharmaceutical company BioLineRx and Novartis Pharma have reached a multi-year strategic collaboration agreement to support the development and commercialization of Israeli-sourced drug candidates.

CMC Biologics and OncoSynergy Enter into an Agreement for Accelerated Process Development of an Investigational Drug to Combat Ebola

CMC Biologics and OncoSynergy have entered into an agreement for process development and GMP manufacture of OS2966 – a novel potential treatment for Ebola. The investigational drug candidate, designed to inhibit a major cellular adhesion receptor (...

Chimerix and ContraVir Pharmaceuticals Establish Strategic Collaboration for Antiviral Drug Candidate CMX157

DURHAM, N.C. and EDISON, N.J., Dec. 18, 2014 /PRNewswire/ -- Chimerix, Inc. (NASDAQ: CMRX) a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, and ContraVir Pharmaceuticals, Inc. (OTCBB: CTRV), a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced today that the companies have ente...

The Europe Pharmacy Audit and Analysis Market is Projected to Grow at a CAGR of 4.4% from 2014 to 2019

FORT WORTH, Texas, December 18, 2014 /PRNewswire/ -- The Europe Pharmacy Audit and Analysis market was valued at $439 million in 2013 and is projected to grow at a CAGR of 4.4% from 2014 to 2019. The Europe pharmacy audit and analysis market is projected to grow significantly during the forecast period owing to various reasons, mainly the reduction of healthcare costs, rising need for integrating...

Wednesday 17th December 2014

Theravectys Launches Its New Website & Wins Deloitte’s Technology Fast50 "2014 Biotech d’Avenir" Award

Villejuif, France, December 18, 2014 --(PR.com)-- A special prize granted by Deloitte Technology Fast 50 Over the last 13 years, this annual event has gathered French leading actors to recognize the fastest-growing companies and the most successful fundraisers of the year. For the first time since its creation, Deloitte Technology Fast 50 showcased Biotech & Medtech and granted Theravectys ...

Shire Considers Bid For NPS Pharma: Report

SAINT HELIER (dpa-AFX) - Irish drug company Shire Plc (SHP.L, SHPG) is considering a bid for NPS Pharmaceuticals Inc. (NPSP), Bloomberg reported citing people familiar with the matter said.Quoting...

Global Gas Chromatography Market Will Be Valued at $3,605.1 Million in 2019 - New Report by MarketsandMarkets

This report categorizes the market into three broad segments, namely, Instrumentation, Accessories & Consumables, and Reagents. http://www.marketsandmarkets.com/Market-Reports/gas-chromatography-market-101656773.html (PRWEB) December 18, 2014 This report estimates the gas chromatography market to be valued at $2,583.6 million in 2014. Growing at a steady CAGR of 6.9%, it expects the market to...


Search BioPortfolio:
Loading
Advertisement
Advertisement

News Quicklinks